Explore All Access
Check if your research matches the topics covered in Bioengineered?
- Degree of match
- Common matching concepts
- Additional journal recommendations
Bioengineered : Impact Factor & More
eISSN: 2165-5987pISSN: 2165-5979
Open AccessShare this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Bioengineered Key Metrics
CiteScore 
2.2
SNIP
1.15
Time to Accept
3
Mo
Time to Publish
View Chart Mo
Time to Publish
Sign up now and unlock a detailed chart of Time to publish for this journal
% of papers by time taken from submission to publication
0 to 3 months21%
4 to 6 months39%
7 to 9 months20%
Above 9 months20%
Did you find this useful?
Topics Covered on Bioengineered
Hepatocellular carcinoma
Transcription factor
Colorectal cancer
Sepsis
Osteosarcoma
Metal
Antisense RNA
Oxidative stress
Signal transduction
Tumor microenvironment
Superoxide dismutase
Autophagy
Ulcerative colitis
Sponge
Immune cell infiltration
Neurofibromatosis
Bioinformatics analysis
Cervical cancer
Lipopolysaccharide
Clinical significance
Bioengineered Journal Specifications
| Overview | |
| Publisher | TAYLOR & FRANCIS INC |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | GBP 2335 |
| Publication Time | 17 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Continuous publication |
| Publication Start Year | 2012 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| License type | CC BY, CC BY-NC |
| OA statement | Visit website |
View less
Planning to publish in Bioengineered ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Bioengineered
Enzymatic synthesis of Hydroxytyrosol from Oleuropein for valorization of an agricultural waste
- 31 Dec 2024
- Bioengineered
Statement of Retraction: Circular RNA CNOT2 knockdown regulates twist family BHLH transcription factor via targeting microRNA 409-3p to prevent breast cancer invasion, migration and epithelial–mesenchymal transition
- 31 Dec 2024
- Bioengineered
Statement of Retraction: The myocardial infarction-associated transcript 2 inhibits lipid accumulation and promotes cholesterol efflux in oxidized low-density lipoprotein-induced THP-1-derived macrophages via inhibiting mitogen-activated protein kinase signaling and activating the nuclear factor erythroid-related factor 2 signaling pathway
- 9 Dec 2024
- Bioengineered
Engineering with Biomedical Sciences Changing the Horizon of Healthcare-A Review
- 16 Sep 2024
- Bioengineered
Unlocking the biodegradative potential of native white-rot fungi: a comparative study of fiberbank organic pollutant mycoremediation
- 2 Sep 2024
- Bioengineered
Statement of Retraction: Propofol inhibits migration and induces apoptosis of pancreatic cancer PANC-1 cells through miR-34a-mediated E-cadherin and LOC285194 signals
- 30 May 2024
- Bioengineered
Enzymatic synthesis of Hydroxytyrosol from Oleuropein for valorization of an agricultural waste
- 31 Dec 2024
- Bioengineered
Statement of Retraction: Circular RNA CNOT2 knockdown regulates twist family BHLH transcription factor via targeting microRNA 409-3p to prevent breast cancer invasion, migration and epithelial–mesenchymal transition
- 31 Dec 2024
- Bioengineered
Statement of Retraction: The myocardial infarction-associated transcript 2 inhibits lipid accumulation and promotes cholesterol efflux in oxidized low-density lipoprotein-induced THP-1-derived macrophages via inhibiting mitogen-activated protein kinase signaling and activating the nuclear factor erythroid-related factor 2 signaling pathway
- 9 Dec 2024
- Bioengineered
Engineering with Biomedical Sciences Changing the Horizon of Healthcare-A Review
- 16 Sep 2024
- Bioengineered
Unlocking the biodegradative potential of native white-rot fungi: a comparative study of fiberbank organic pollutant mycoremediation
- 2 Sep 2024
- Bioengineered
Statement of Retraction: Propofol inhibits migration and induces apoptosis of pancreatic cancer PANC-1 cells through miR-34a-mediated E-cadherin and LOC285194 signals
- 30 May 2024
- Bioengineered
Compare Similar Journals with Bioengineered
Select Journals to Compare with Bioengineered
Total journals - 9
You can select up to 3 Journals at a time
Frontiers in Oncology
Publisher: FRONTIERS MEDIA SA
Oncology Letters
Publisher: SPANDIDOS PUBL LTD
OncoTargets and Therapy
Publisher: DOVE MEDICAL PRESS LTD
Cancer Cell International
Publisher: BMC
Molecular Medicine Reports
Publisher: SPANDIDOS PUBL LTD
International Journal of Molecular Sciences
Publisher: MDPI
Journal of Cellular and Molecular Medicine
Publisher: WILEY
Cancer Management and Research
Publisher: DOVE MEDICAL PRESS LTD
BioMed Research International
Publisher: HINDAWI LTD
0 Journals Selected to compare with
Bioengineered
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
FAQs on Bioengineered
How long has Bioengineered been actively publishing? 
Bioengineered has been in operation since 2012 till date.
What is the publishing frequency of Bioengineered?
Bioengineered published with a Continuous publication frequency.
How many articles did Bioengineered publish last year?
In 2023, Bioengineered publsihed 63 articles.
What is the eISSN & pISSN for Bioengineered?
For Bioengineered, eISSN is 2165-5987 and pISSN is 2165-5979.
What is Citescore for Bioengineered?
Citescore for Bioengineered is 2.2.
What is SNIP score for Bioengineered?
SNIP score for Bioengineered is 1.15.
Who is the publisher of Bioengineered?
TAYLOR & FRANCIS INC is the publisher of Bioengineered.
